Your browser doesn't support javascript.
Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021.
Zuo, Zhongbao; Yang, Chunli; Ye, Fei; Wang, Miaochan; Wu, Jing; Tao, Chengjiang; Xun, Yunhao; Li, Zhaoyi; Liu, Shourong; Huang, Jinsong; Xu, Aifang.
  • Zuo Z; Department of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Zhejiang, 310023, China.
  • Yang C; Department of Clinical Laboratory, The 903rd Hospital of PLA, Zhejiang, 310013, China.
  • Ye F; Health Examination Center, Hangzhou Xixi Hospital, Zhejiang, 310023, China.
  • Wang M; Department of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Zhejiang, 310023, China.
  • Wu J; Department of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Zhejiang, 310023, China.
  • Tao C; Department of Obstetrics and Gynecology, Hangzhou Xixi Hospital, Zhejiang, 310023, China.
  • Xun Y; Department of Hepatology, Hangzhou Xixi Hospital, Zhejiang, 310023, China.
  • Li Z; Science and Education Department, Hangzhou Xixi Hospital, Zhejiang, 310023, China.
  • Liu S; Department of Hepatology, Hangzhou Xixi Hospital, Zhejiang, 310023, China.
  • Huang J; Department of Hepatology, Hangzhou Xixi Hospital, Zhejiang, 310023, China.
  • Xu A; Department of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Zhejiang, 310023, China. 13616500869@163.com.
BMC Public Health ; 23(1): 217, 2023 02 01.
Article in English | MEDLINE | ID: covidwho-2224155
ABSTRACT

BACKGROUND:

The ongoing benefits of coronavirus disease 2019 (COVID-19) nonpharmaceutical interventions (NPIs) for respiratory infectious diseases in China are still unclear. We aimed to explore the changes in seven respiratory infectious diseases before, during, and after COVID-19 in China from 2010 to 2021.

METHODS:

The monthly case numbers of seven respiratory infectious diseases were extracted to construct autoregressive integrated moving average (ARIMA) models. Eight indicators of NPIs were chosen from the COVID-19 Government Response Tracker system. The monthly case numbers of the respiratory diseases and the eight indicators were used to establish the Multivariable generalized linear model (GLM) to calculate the incidence rate ratios (IRRs).

RESULTS:

Compared with the year 2019, the percentage changes in 2020 and 2021 were all below 100% ranging from 3.81 to 84.71%. Pertussis and Scarlet fever started to increase in 2021 compared with 2020, with a percentage change of 183.46 and 171.49%. The ARIMA model showed a good fit, and the predicted data fitted well with the actual data from 2010 to 2019, but the predicted data was bigger than the actual number in 2020 and 2021. All eight indicators could negatively affect the incidence of respiratory diseases. The seven respiratory diseases were significantly reduced during the COVID-19 pandemic in 2020 and 2021 compared with 2019, with significant estimated IRRs ranging from 0.06 to 0.85. In the GLM using data for the year 2020 and 2021, the IRRs were not significant after adjusting for the eight indicators in multivariate analysis.

CONCLUSION:

Our study demonstrated the incidence of the seven respiratory diseases decreased rapidly during the COVID-19 pandemic in 2020 and 2021. At the end of 2021, we did see a rising trend for the seven respiratory diseases compared to the year 2020 when the NPIs relaxed in China, but the rising trend was not significant after adjusting for the NPIs indicators. Our study showed that NPIs have an effect on respiratory diseases, but Relaxation of NPIs might lead to the resurgence of respiratory diseases.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiration Disorders / Respiratory Tract Diseases / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: BMC Public Health Journal subject: Public Health Year: 2023 Document Type: Article Affiliation country: S12889-023-15081-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiration Disorders / Respiratory Tract Diseases / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: BMC Public Health Journal subject: Public Health Year: 2023 Document Type: Article Affiliation country: S12889-023-15081-4